Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Semaglutide reduces risk of major cardiovascular events by 20%, finds study. | Pepdox

Home
Search
PMID 37957004

Semaglutide reduces risk of major cardiovascular events by 20%, finds study.

BMJ (Clinical research ed.)2023PMID: 37957004

View on PubMed DOI: 10.1136/bmj.p2668

Authors

Wise, Jacqui